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It is well known that cytotoxic T cells (CTL) and natural killer (NK) cells play an important role in resistance to herpes simplex virus (HSV) infection.
To study the function of CTL and NK cells in vitro, 51Cr release cytotoxicity assays have been universally used. However, it is important to know whether CTL or NK cells can limit viral replication in target cells, because lysis of virus-infected cells after virion assembly may cause a more rapid spread of viral infection in vivo.
It has been shown in the murine system that the adoptive transfers of influenza virus-specific CTL clones and lymphocytic choriomeningitis virus (LCMV)-specific CTL clones result in a reduction of virus titre in the lung and the spleen, respectively (Lin & Askonas, 1981 ; Byrne & Oldstone, 1984) and that the transfer of HSV-specific CTL clones protects the recipients from death following infection With HSV (Sethi et al., 1983) . In mice in which NK cell activity is depleted by injection of anti-asialo GM1, HSV titres in the brain, liver and spleen are higher than in the organs of control mice (Habu et al., 1984) . Furthermore, the adoptive transfer of cloned NK cells confers resistance to mice infected with murine cytomegalovirus (Bukowski et al., 1985) . Although these data suggest that CTL and NK cells prevent the spread of viral infection in vivo, the ability of these cells to inhibit directly the viral replication in target cells has not been demonstrated.
Recently, it has become possible to generate virus-specific CTL and NK cell clones using interleukin-2 (IL-2) (Lin & Askonas, 1980; Warner & Dennert, 1982) . This method is very useful in the study of the functions of CTL and NK cells. In this study, we examined the defensive functions of CTL and NK cells against HSV replication in target cells, and showed that virusspecific human CTL and human NK cells could by themselves limit virus replication in vitro.
Human CTL clones directed against HSV-infected cells and human NK cell clones were generated as previously detailed (Yasukawa & Zarling, 1984a, b) . Briefly, peripheral blood lymphocytes (PBL) obtained from an HSV-1 seropositive donor were stimulated with u.v. lightinactivated HSV-1 strain KOS in RPMI 1640 medium supplemented with 10 ~o heat-inactivated pooled human serum. Seven days later, the cells were restimulated with the u.v.-inactivated HSV-1, and 3 days following restimulation, the ceils were seeded at a concentration of 1 cell/well in round-bottom microtitre wells containing 0.2 ml RPMI 1640 medium supplemented with 0000-6658 © 1985 SGM 10 ~ heat-inactivated human serum and 7 ~ delectinated IL-2 (Cellular Products, Buffalo, N.Y., U.S.A.), u.v.-inactivated HSV-1, and mitomycin C-treated autologous PBL as feeder cells. The growing cells were transferred to l 6 mm wells and the cell numbers increased. The cytotoxic activities of the clones were tested by SlCr release assay (Yasukawa & Zarling, 1984a) . Cells (3 × 10 6) from a lymphoblastoid cell line (LCL), which was established by infecting B cells with Epstein-Barr virus, and confluent human foreskin fibroblasts (HFF) in a 75 cm z culture flask were infected with 3 × l07 p.f.u, of HSV-1 strain KOS or HSV-2 strain 186 in serum-free medium for 1 h at 37 °C. The HSV-infected LCL and HFF were then cultured overnight in RPMI 1640 medium supplemented with 10~ heat-inactivated foetal calf serum (FCS) and Dulbecco's modified Eagle's medium (DMEM) supplemented with 10~ heat-inactivated FCS, respectively, prior to labelling with Na251CrO4 for use as target cells. Five x 103 51Cr-labelled HSV-infected target cells and 1 x 105 cloned cells, in 0-2 ml RPMI 1640 medium supplemented with 10~ heat-inactivated FCS, were incubated in round-bottom microtitre wells for 5 h at 37 °C in a 5~ CO2 incubator. Then 0.1 ml supernatant was removed from each well and counted in a gamma counter. Percentage specific 5lCr release was calculated as follows: (c.p.m. experimental release -c.p.m, spontaneous release) x 100/(c.p.m. maximum release -c.p.m. spontaneous release). Spontaneous release did not exceed 15~0 of the maximum release.
The replication of HSV in LCL and HFF was examined as follows. Three × 106 LCL and 3 x 106 trypsinized HFF were infected with 3 x 107 p.f.u, of HSV-1 strain KOS or HSV-2 strain 186 in serum-free RPMI 1640 medium. After 1 h adsorption at 37 °C, HSV-infected cells were washed three times to remove free viruses. Then 5 × 104 HSV-infected cells suspended in 1 ml RPMI 1640 medium supplemented with 10~ heat-inactivated FCS were incubated in 12 × 75 mm culture tubes (Falcon 2003) at 37 °C in a 5~ CO2 incubator. After 4, 8, 12, 20 and 24 h, the incubation was stopped and the tubes were stored at -76 °C until titrations were performed.
Virus titrations were performed by plaque-forming assay as follows. HSV-infected cells in culture medium were frozen and thawed repeatedly. Then 0-1 ml of successive 10-fold dilutions were plated on the monolayers of Vero cells in 24 mm wells. Three wells were used for each virus dilution. After adsorption for 1 h at 37 °C, each well was overlaid with 1 ml DMEM supplemented with 5 ~ FCS and 1 ~ methylcellulose. After 2 days, each well was stained with neutral red, and the virus titre was determined by counting virus plaques. Virus titres were expressed as log1 o p.f.u./ml. Results are shown as the arithmetic mean + standard deviation.
The abilities of clones to inhibit the replication of HSV were examined as follows. LCL and HFF were infected with HSV-1 or HSV-2 as described above. After washing cells repeatedly, 1 x 104 HSV-infected cells were cultured with 5 x 105 clone cells in 0.2 ml RPMI 1640 medium supplemented with 10~ heat-inactivated FCS in round-bottom microtitre wells. HSV-infected cells were also added to wells containing medium alone. After 24 h, the incubation was stopped and microtitre plates were stored at -76 °C until titrations were performed. Virus titrations were performed as described above using 16 mm wells instead of 24 mm wells. Student's t-test was used to compare virus titres from different wells.
The cytotoxic activities of the clones generated from PBL of individual MY were tested against HSV-l-or HSV-2-infected autologous LCL, HSV-l-infected allogeneic LCL that shared no HLA-A, HLA-B or HLA-DR antigens with MY, and HSV-l-infected allogeneic HFF that shared no HLA-A or HLA-B with MY. As shown in Table 1 , the clones were divided into four categories. Clones such as MY-19 and MY-38 were cytotoxic for HSV-l-infected autologous LCL but not for HSV-2-infected autologous LCL or HSV-l-infected allogeneic cells. These clones are referred to as HSV-l-specific CTL clones. The second group referred to as HSV typecommon CTL clones included MY-7 and MY-16. These were cytotoxic for HSV-l-infected and HSV-2-infected autologous LCL but not for HSV-l-infected allogeneic cells. The third group included MY-5 and MY-48 which were considered as NK cell clones. Both lysed HSV-1-infected and HSV-2-infected autologous LCL, HSV-l-infected allogeneic LCL, and HSV-1-infected HFF sharing no HLA antigens with MY. These clones showed high cytotoxic activity against the NK-sensitive K562 leukaemia cell line (data not shown). The fourth group included MY-10 and MY-37 which were not cytotoxic for HSV-infected cells.
Then we examined the ability of these cytotoxic and non-cytotoxic clones to inhibit the HSV HSV-1 stimulation of PBL from HSV-1 seropositive donor MY were tested for their ability to lyse HSV-I-or HSV-2-infected autologous LCL, HSV-l-infected allogeneic LCL (M J) that shared no HLA-A, HLA-B or HLA-DR antigens with MY, and HSV-l-infected allogeneic HFF that shared no HLA-A or -B antigens with MY. The effector to target cell ratio was 20:1. t HSV titres significantly different from the titre without effector cells are given in bold type (P < 0-001).
replication in target cells and compared the specificities required for cell killing with that of inhibiting viral replication in various target cells. As shown in Table 2 , after an incubation at 37 °C for 24 h, a productive infection was established in LCL and HFF. However, as shown in Table 3 , virus titres after 24 h of infection in the presence of CTL and NK cell clones were significantly lower than in the absence of cytotoxic clones. CTL clones reduced infectious virus titres in autologous ceils; however, they had no effect on the virus growth in allogeneic ceils. HSV-l-specific CTL clones inhibited only HSV-1 replication; on the other hand, HSV typecommon CTL clones showed the ability to limit the replication of both HSV-1 and HSV-2. In contrast to CTL, NK cell clones inhibited HSV replication in autologous LCL, allogeneic LCL and allogeneic HFF. Non-cytotoxic clones showed no inhibitory activity against HSV replication. Although the importance of CTL and NK cells in protection and recovery from HSV infection has been proven by in vivo studies in the murine system (Sethi et al., 1983; Habu et al., 1984) , how they exert their antiviral functions has remained uncertain. In this study, we asked whether CTL and NK cells by themselves inhibit viral replication in target cells or whether their antivirat activities depend on the functions of other cell populations. By using clones of HSVspecific CTL and NK cells, we have demonstrated that CTL and NK cells could limit the virus growth. Target cells used in this experiment were infected with HSV at high multiplicity to infect all cells at the initial time of incubation. It was shown by immunofluorescence microscopy and electron microscopy that more than 90 ~ of the target cells expressed HSV glycoproteins on their surface and contained many viral particles in their nuclei and cytoplasm after 24 h of infection (unpublished observation). These data suggested that HSV-specific CTL and NK cells not only prevented spread of HSV infection to contiguous cells by killing HSV-infected cells but also directly inhibited the replication of HSV in target cells.
Lysis by virus-specific CTL can only be mediated via recognition of viral antigen in the context of self major histocompatibility complex (MHC), H-2 in mice and HLA in humans (for review, see Zinkernagel & Doherty, 1979; Biddison, 1982) . On the other hand, NK cells are capable of lysing various target cells without MHC restriction. From the data presented here, HSV-specific CTL clones showed the same immunological specificities when inhibiting a productive virus infection and when lysing target cells. Furthermore, NK cell clones showed the ability to inhibit the replication of both HSV-1 and HSV-2 in autologous as well as in allogeneic cells. These HSV-type non-specificity and MHC non-restricted patterns are precisely characteristic of human NK cells in cytotoxicity (Yasukawa & Zarling, 1983) . Although it has been reported that a reduction of virus titres in vivo by adoptive transfer of LCMV-specific murine cloned CTL was genetically restricted (Byrne & Oldstone, 1984) , we now provide the first evidence in the human system that the ability to reduce the virus titre in vitro is genetically restricted in CTL but not in NK cells.
The mechanisms by which CTL and NK cells inhibit viral replication were not clarified in this study. It has been reported that human HSV-specific CTL and NK cells can lyse virusinfected target cells in a short term SlCr release assay (Sethi et al., 1980; Yasukawa & Zarling, 1983) . These findings suggest that the low virus yields obtained in our experiments may be attributable to the CTL-and NK cell-mediated lysis of infected target cells before virus assembly. On the other hand, it has been shown that an influenza virus-specific murine CTL clone releases gamma-interferon on contact with the influenza virus-infected cells (Morris et al., 1982) . Furthermore, we reported that HSV-specific human CTL clones produce an IL-2-1ike lymphokine on co-culture with HSV-infected target cells (Yasukawa & Zarling, 1984b) . In addition to these reports, the finding that NK cells also mediate some lymphokines (Kasahara et al., 1983) suggests that some humoral factors released from cytotoxic effector cells might be important in limiting viral spread. However, a recent report on the production of gammainterferon by LCMV-specific murine CTL clones did not directly correlate with CTL-mediated cytotoxicity (Anderson et al., 1985) , demonstrating variety in the mechanisms by which cytotoxic effector cells exert their antiviral functions. This problem is currently under investigation in our laboratory.
Note added in prot?f After submission of this manuscript, an observation that human NK cells inhibited the growth of HSV in target cells in vitro was reported by Fitzgerald et al. [Journal of Immunology 134, 2666 -2672 ].
